Form 4 for PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Accepted 2024-01-10 00:00:00 ET · period of report 2024-01-09 · accession 0001299130-24-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-10 | 2024-01-09 | PACB | Van Oene Mark | See Remarks | S - Sale | $7.77 | -31.0K | 910.2K | -3% | -$241.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-09 | S | D | 31,012 | $7.77 | 910,171 | D | — | — | (F1) Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units. (F2) This sale price represents the weighted average sale price of the shares sold ranging from $7.54 to $8.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. (F3) Includes 1,414 shares purchased on September 1, 2023 under the Company's 2010 Employee Stock Purchase Plan. |